Lungeinfektioner med nontuberkuløse mykobakterier

Andreas Arnholdt Pedersen; Victor Næstholt Dahl; Ole Hilberg; Anders Løkke Ottesen; Andreas Fløe

doi:10.61409/V06230603

Lungeinfektioner med nontuberkuløse mykobakterier

Andreas Arnholdt Pedersen, Victor Næstholt Dahl, Ole Hilberg, Anders Løkke Ottesen, Andreas Fløe

Aarhus Universitetshospital

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.

Bidragets oversatte titel	Pulmonary infections with nontuberculous mycobacteria
Originalsprog	Dansk
Artikelnummer	V06230603
Tidsskrift	Ugeskrift for Læger
ISSN	0041-5782
DOI	https://doi.org/10.61409/V06230603
Status	E-pub ahead of print - 1. apr. 2024

Emneord

Anti-Bacterial Agents/therapeutic use
Humans
Lung Diseases/drug therapy
Mycobacterium Infections, Nontuberculous/drug therapy
Nontuberculous Mycobacteria
Pneumonia

Dokumenter og links

10.61409/V06230603Licens: CC BY-NC-ND

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{2c1200a809d64d7a9200742e67f7c4b6,

title = "Lungeinfektioner med nontuberkul{\o}se mykobakterier",

abstract = "This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.",

keywords = "Anti-Bacterial Agents/therapeutic use, Humans, Lung Diseases/drug therapy, Mycobacterium Infections, Nontuberculous/drug therapy, Nontuberculous Mycobacteria, Pneumonia",

author = "Pedersen, {Andreas Arnholdt} and Dahl, {Victor N{\ae}stholt} and Ole Hilberg and Ottesen, {Anders L{\o}kke} and Andreas Fl{\o}e",

year = "2024",

month = apr,

day = "1",

doi = "10.61409/V06230603",

language = "Dansk",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Lungeinfektioner med nontuberkuløse mykobakterier

AU - Pedersen, Andreas Arnholdt

AU - Dahl, Victor Næstholt

AU - Hilberg, Ole

AU - Ottesen, Anders Løkke

AU - Fløe, Andreas

PY - 2024/4/1

Y1 - 2024/4/1

N2 - This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.

AB - This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.

KW - Anti-Bacterial Agents/therapeutic use

KW - Humans

KW - Lung Diseases/drug therapy

KW - Mycobacterium Infections, Nontuberculous/drug therapy

KW - Nontuberculous Mycobacteria

KW - Pneumonia

U2 - 10.61409/V06230603

DO - 10.61409/V06230603

M3 - Tidsskriftartikel

C2 - 38606709

SN - 0041-5782

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

M1 - V06230603

ER -

Lungeinfektioner med nontuberkuløse mykobakterier

Abstract

Emneord

Dokumenter og links

SDU link

Fingeraftryk

Citationsformater